BCDA
Income statement / Annual
Last year (2023), BioCardia, Inc.'s total revenue was $477,000.00,
a decrease of 64.72% from the previous year.
In 2023, BioCardia, Inc.'s net income was -$11.57 M.
See BioCardia, Inc.’s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
Operating Revenue |
$477,000.00
|
$1.35 M
|
$1.02 M
|
$145,000.00
|
$710,000.00
|
$625,000.00
|
$479,000.00
|
$576,000.00
|
$517,000.00
|
$427,000.00
|
Cost of Revenue |
$7.73 M |
$11.90 M |
$640,000.00 |
$4,000.00 |
$358,000.00 |
$517,000.00 |
$690,000.00 |
$746,000.00 |
$0.00 |
$0.00 |
Gross Profit |
-$7.25 M |
-$10.55 M |
$375,000.00 |
$141,000.00 |
$352,000.00 |
$108,000.00 |
-$211,000.00 |
-$170,000.00 |
$517,000.00 |
$427,000.00 |
Gross Profit Ratio |
-15.2 |
-7.8 |
0.37 |
0.97 |
0.5 |
0.17 |
-0.44 |
-0.3 |
1 |
1 |
Research and Development
Expenses |
$7.73 M
|
$8.83 M
|
$8.56 M
|
$9.81 M
|
$8.56 M
|
$8.45 M
|
$5.80 M
|
$3.33 M
|
$0.00
|
$0.00
|
General & Administrative
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$3.73 M
|
$0.00
|
$198,000.00
|
$196,000.00
|
Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$2.66 M
|
$0.00
|
$0.00
|
$0.00
|
Selling, General &
Administrative Expenses |
$4.40 M
|
$4.42 M
|
$5.09 M
|
$5.86 M
|
$6.00 M
|
$5.76 M
|
$6.40 M
|
$4.11 M
|
$198,000.00
|
$196,000.00
|
Other Expenses |
$0.00 |
-$6,000.00 |
-$2,000.00 |
-$2,000.00 |
-$2,000.00 |
-$3,000.00 |
$2,000.00 |
-$2,000.00 |
$0.00 |
$0.00 |
Operating Expenses |
$12.12 M |
$13.25 M |
$13.65 M |
$15.67 M |
$14.57 M |
$14.21 M |
$12.19 M |
$7.44 M |
$198,000.00 |
$196,000.00 |
Cost And Expenses |
$12.12 M |
$13.25 M |
$13.65 M |
$15.67 M |
$14.92 M |
$14.73 M |
$12.88 M |
$8.18 M |
$198,000.00 |
$196,000.00 |
Interest Income |
$0.00 |
$0.00 |
$9,000.00 |
$21,000.00 |
$87,000.00 |
$118,000.00 |
$95,000.00 |
$0.00 |
$3,000.00 |
$3,000.00 |
Interest Expense |
$0.00 |
$6,000.00 |
$0.00 |
$3,000.00 |
$112,000.00 |
$0.00 |
$95,000.00 |
$1.74 M |
$3,000.00 |
$3,000.00 |
Depreciation &
Amortization |
$84,000.00
|
$377,000.00
|
$640,000.00
|
$566,000.00
|
$551,000.00
|
$203,000.00
|
$78,000.00
|
$39,000.00
|
$0.00
|
$0.00
|
EBITDA |
-$11.56 M
|
-$11.82 M
|
-$12.57 M
|
-$14.44 M
|
-$14.05 M
|
-$13.90 M
|
-$12.23 M
|
-$8.54 M
|
$319,000.00
|
$231,000.00
|
EBITDA Ratio |
-24.23 |
-8.8 |
-12.38 |
-106.5 |
-19.74 |
-22.24 |
-25.73 |
-11.47 |
0.62 |
0.54 |
Operating Income Ratio
|
-24.41
|
-8.8
|
-12.44
|
-107.1
|
-20.02
|
-22.56
|
-25.9
|
-13.21
|
0.62
|
0.54
|
Total Other
Income/Expenses Net |
$73,000.00
|
-$6,000.00
|
$7,000.00
|
$525,000.00
|
-$496,000.00
|
$115,000.00
|
$97,000.00
|
-$2.70 M
|
$3,000.00
|
$3,000.00
|
Income Before Tax |
-$11.57 M |
-$11.91 M |
-$12.62 M |
-$15.00 M |
-$14.71 M |
-$13.99 M |
-$12.31 M |
-$10.31 M |
$322,000.00 |
$234,000.00 |
Income Before Tax Ratio
|
-24.26
|
-8.81
|
-12.44
|
-103.48
|
-20.72
|
-22.38
|
-25.7
|
-17.9
|
0.62
|
0.55
|
Income Tax Expense |
$0.00 |
$6,000.00 |
-$2,000.00 |
$1,000.00 |
$110,000.00 |
-$115,000.00 |
-$192,000.00 |
$5.40 M |
-$6,000.00 |
-$6,000.00 |
Net Income |
-$11.57 M |
-$11.91 M |
-$12.62 M |
-$15.01 M |
-$14.82 M |
-$13.87 M |
-$12.31 M |
-$10.31 M |
$322,000.00 |
$234,000.00 |
Net Income Ratio |
-24.26 |
-8.81 |
-12.43 |
-103.48 |
-20.87 |
-22.2 |
-25.7 |
-17.9 |
0.62 |
0.55 |
EPS |
-8.19 |
-10.08 |
-11.19 |
-22.24 |
-39.38 |
-48.8 |
-43.54 |
-166.33 |
27.86 |
20.5 |
EPS Diluted |
-8.19 |
-10.08 |
-11.19 |
-22.24 |
-39.38 |
-48.8 |
-43.54 |
-166.33 |
27.86 |
20.5 |
Weighted Average Shares
Out |
$1.41 M
|
$1.18 M
|
$1.13 M
|
$674,579.00
|
$376,289.00
|
$284,279.00
|
$282,671.00
|
$61,987.00
|
$11,558.00
|
$11,414.00
|
Weighted Average Shares
Out Diluted |
$1.41 M
|
$1.18 M
|
$1.13 M
|
$674,579.00
|
$376,289.00
|
$284,279.00
|
$282,671.00
|
$61,987.00
|
$11,558.00
|
$11,414.00
|
Link |
|
|
|
|
|
|
|
|
|
|